# Retinoic Acid Therapy and Regulation of Salivary and Serum IL-1β, IL-8 and MCP-1 Levels

> **NCT06879795** · — · COMPLETED · sponsor: **Medipol University** · enrollment: 24 (actual)

## Conditions studied

- Acne Vulgaris
- Gingivitis and Periodontal Diseases
- Saliva Collection
- Inflammation Biomarkers
- Vitamin A

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06879795
- **Lead sponsor:** Medipol University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-01
- **Primary completion:** 2024-07-01
- **Final completion:** 2024-07-01
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06879795

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06879795, "Retinoic Acid Therapy and Regulation of Salivary and Serum IL-1β, IL-8 and MCP-1 Levels". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06879795. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*